搜索临床试验以:羟乙基纤维素 0.19%
总计2590个结果
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Lamellar Biomedical Ltd完全的
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial Hospital; The First People's Hospital of Hefei; Hefei Binhu Hospital未知滤泡性淋巴瘤 | 套细胞淋巴瘤 | 慢性淋巴细胞白血病 | 急性淋巴细胞白血病 | 弥漫性大细胞淋巴瘤 | B细胞幼淋巴细胞白血病中国
-
Prof Gérard WAEBERCentre Hospitalier Universitaire Vaudois; University of Lausanne; Center for Primary Care and...终止
-
University Hospital, Basel, SwitzerlandGottfried und Julia Bangerter-Rhyner-Stiftung完全的
-
The First Affiliated Hospital of Nanchang University完全的
-
Novo Nordisk A/S完全的肾脏疾病 | 泌尿系统疾病 | 遗传病 | 原发性高草酸尿症 1 型 (PH1) | 原发性高草酸尿症 2 型 (PH2)波兰, 美国, 英国, 新西兰, 澳大利亚, 加拿大, 法国, 德国, 以色列, 意大利, 日本, 黎巴嫩, 荷兰, 罗马尼亚, 西班牙
-
Global Health Drug Discovery InstituteCMAX Clinical Research Pty Limited; Avance Clinical完全的
-
University Hospital, Basel, SwitzerlandFresenius AG完全的
-
Herlev and Gentofte HospitalGöteborg University; University of Copenhagen; Sahlgrenska University Hospital, Sweden完全的
-
Seoul National University HospitalGreen Cross Corporation; LSK Global Pharma Services Co. Ltd.完全的
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial Hospital未知滤泡性淋巴瘤 | 套细胞淋巴瘤 | 慢性淋巴细胞白血病 | 急性淋巴细胞白血病 | 弥漫性大细胞淋巴瘤 | B细胞幼淋巴细胞白血病中国
-
King's College Hospital NHS TrustKing's College London; University of Leicester完全的
-
French National Agency for Research on AIDS and...Takeda终止
-
Chimerix终止严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) | 急性肺损伤 | 2019 冠状病毒病 (COVID-19)美国
-
University Hospital, LimogesVanderbilt University Medical Center; Revimmune终止
-
Baiya Phytopharm Co., Ltd.尚未招聘
-
Merck Sharp & Dohme LLC完全的
-
IRCCS National Neurological Institute "C. Mondino...University of Pavia招聘中
-
Niels Van Regenmortel完全的
-
Ichor Medical Systems IncorporatedUS Army Medical Research Institute of Infectious Diseases完全的
-
National Institute of Allergy and Infectious Diseases...招聘中